Ecosystem Opportunity Following Repligen's Sep 2023 acquisition of FlexBiosys, the company sits within a broader fluid-management ecosystem, enabling cross-selling opportunities to Repligen's existing customer base and alignment with its product strategy.

Quality Compliance FlexBiosys holds ISO 9001:2015 certification, operates in an ISO Class 7 cleanroom, and carries SBA 8(a) along with WBENC certified WBE and WOSB statuses, which can support procurement requirements in regulated biopharma and supplier-diversity programs.

Tailored Speed The company provides fully customized bioprocess containers and manifold assemblies with short lead times, appealing to startups, CROs/CMOs, and teams that need rapid development to production transitions.

East Coast Focus Located in New Jersey with a US manufacturing footprint, FlexBiosys can target Northeast biotech clusters and mid-market biopharma buyers seeking agile, locally sourced single-use system components.

System Integration FlexBiosys combines bags, tubing assemblies and unbiased guidance on filters, sensors and accessories, presenting an opportunity to position as a one-stop supplier for complete bioprocess single-use systems within the Repligen ecosystem.